Environmental Impact of Common Inhalers Revealed in New Study
A recent study reveals that common inhalers, especially metered-dose types, contribute significantly to greenhouse gas emissions, urging policy and technology reforms for sustainable healthcare.
Recent research highlights the significant environmental footprint of inhalers used to manage respiratory conditions like asthma and COPD. The study, conducted by researchers at UCLA and Harvard, analyzed data from 2014 to 2024 and found that inhalers, particularly metered-dose inhalers (MDIs), contribute substantially to greenhouse gas emissions. MDIs utilize hydrofluoroalkane (HFA) propellants, potent greenhouse gases that account for approximately 98% of the emissions from these devices. Annually, the emissions from inhalers used in the US alone are comparable to the pollution produced by over half a million cars.
The study emphasized that while inhalers are vital for many patients, particularly young children and older adults with limited inhalation capacity, there are sustainable alternatives. Dry powder inhalers and soft mist inhalers do not rely on HFA propellants and are less harmful to the environment, yet they are underutilized partly due to insurance and market barriers.
Researchers used a national drug database to estimate the carbon footprint of inhalers and found that inhalers used by US patients under various insurance plans resulted in approximately 24.9 million metric tons of CO2 equivalents over a decade. The findings suggest a pressing need for policy reforms to improve access to environmentally friendly inhalers, which are already used in countries like Sweden and Japan without compromising medical efficacy.
The study's lead author, William Feldman, stresses that the goal isn’t to blame patients but to encourage societal and policy changes to foster sustainable healthcare practices. The report advocates for making lower-emission inhalers more affordable and accessible, warning that new, expensive low-global-warming inhalers might leave behind vulnerable populations without adequate insurance coverage.
This research underscores the importance of addressing the climate impact of medical devices and highlights opportunities to reimagine inhaler technology and healthcare policy to reduce environmental harm while maintaining high-quality care.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Lessons from COVID-19 Predictions: Navigating Uncertainty in Pandemic Modeling
This article explores the lessons learned from COVID-19 pandemic modeling failures and offers strategies to enhance future epidemic preparedness through systemic improvements and ensemble modeling techniques.
How Immune Cells Use 'Mini-Hulk' Mechanics to Navigate Tight Spaces in Tissues
A groundbreaking study uncovers how immune cells, dubbed 'mini-Hulks', generate forces to push through tissues, ensuring effective immune surveillance and response. This mechanism involves a central actin structure that helps dendritic cells navigate tight spaces safely, with implications for understanding immune deficiencies.
promising new investigational treatment shows potential for Crohn's disease remission
A new investigational therapy targeting TL1A shows significant potential to induce remission in Crohn's disease, offering hope for better treatment options. Recent studies highlight rapid response and possible effects on fibrosis crucial in disease management.
Higher Normal Sodium Levels Associated with Greater Heart Disease Risk
A new study reveals that sodium levels at the higher end of the normal range may increase the risk of hypertension and heart failure, highlighting the importance of hydration in cardiovascular disease prevention.